588. Deputy David Maxwell asked the Minister for Health the reason tirzepatide (Mounjaro), despite being authorised for the treatment of type 2 diabetes, is not currently covered under the medical card, long-term illness scheme or drugs payment scheme; and if she will outline the current position regarding access to this medication through the State schemes. [66674/26]

Summary

588. Deputy David Maxwell asked the Minister for Health the reason tirzepatide (Mounjaro), despite being authorised for the treatment of type 2 diabetes, is not currently covered under the medical card, long-term illness scheme or drugs payment scheme; and if she will outline the current position regarding access to this medication through the State schemes. [66674/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 22 September 2026

   Medicinal Products

   588. Deputy David Maxwell asked the Minister for Health the reason tirzepatide (Mounjaro), despite being authorised for the treatment of type 2 diabetes, is not currently covered under the medical card, long-term illness scheme or drugs payment scheme; and if she will outline the current position regarding access to this medication through the State schemes. [66674/26]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 22 September 2026

  ViewDownloadOpen at official source

Sponsors

• David Maxwell · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.